Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Douglas W. Sborov, MD shares tools for physicians to identify patients for combination therapies with CAR-T.
Up next
Jan 14, 2026
Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: post anti-CD38 therapy
Dx dialogues: other potential treatments for indolent systemic mastocytosis
Dx dialogues: advancements in treating indolent systemic mastocytosis
What is cancer immunotherapy?
Oct 28, 2014
Dx dialogues: diagnosing indolent systemic mastocytosis
What is combination therapy for CLL?
Mar 4, 2021
Dx dialogues: common and emerging treatments for CRSwNP
What role do biopsies play in personalized medicine?
Mar 4, 2016
What's the difference between immunotherapy and chemotherapy?
Jan 22, 2020